Stanley Druckenmiller (Duquesne Family Office) exit Ultragenyx Pharmaceutical Inc.
Stanley Druckenmiller (Duquesne Family Office) exit $-3.1K of disclosed value in Ultragenyx Pharmaceutical Inc..
Signal
Investor Move
Action
Exit
Capital
$-3.1K disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.